<?xml version="1.0" encoding="UTF-8"?>
<p id="Par97">It is considered dangerous to continue AIT in individuals with suspected or confirmed infection with COVID-19 [
 <xref ref-type="bibr" rid="CR67">67</xref>]. Moreover, it is useful to avoid confounding effects such as the accentuation of symptoms in subjects with seasonal symptoms (allergic rhinitis and/or asthma episodes), also following the administration of immunotherapy and possible concomitant viral infections. In this case, it would be more complex to effectively distinguish the clinical manifestations, viral and/or allergic, often present concomitantly and which could delay an adequate diagnosis and treatment of the COVID-19 infection.
</p>
